KUWAIT CITY — The Ministry of Health has issued a new decree approving price caps on 268 pharmaceutical products, including medicines and nutritional supplements, in an effort to enhance affordability and support the national healthcare system. Announced on May 17 by Minister of Health Dr. Ahmed Al-Awadhi, the move aims to position these products among the most competitively priced within the Gulf region.

This measure is part of the ministry’s broader initiative to prioritize patient welfare while maintaining the sustainability and operational efficiency of Kuwait’s healthcare infrastructure. With this latest decision, the total number of regulated pharmaceutical items with government-approved prices has reached 1,922.

The decree reflects the government's ongoing efforts to regulate medicine costs amid rising healthcare demands, ensuring that essential treatments remain accessible to the public without compromising the quality or availability of healthcare services. By capping prices on a wide range of pharmaceutical goods, officials hope to balance affordability for consumers with the economic viability of pharmaceutical providers and healthcare institutions.

Details on the specific products included in this pricing initiative have not been released publicly, but the inclusion of nutritional supplements alongside medicines indicates a comprehensive approach to healthcare affordability. The Ministry of Health’s actions follow regional trends toward greater regulation of drug prices as part of broader healthcare reform efforts across the Gulf Cooperation Council countries.

Healthcare experts have noted that such price regulation could help mitigate financial barriers to treatment and promote equitable access to medicines. However, some industry stakeholders caution that stringent price controls must be carefully managed to avoid potential shortages or reduced incentives for pharmaceutical companies to introduce new products to the market.

As Kuwait continues to expand its pharmaceutical price regulation framework, officials emphasize a balanced approach designed to protect consumers while ensuring the long-term viability of the healthcare sector remains intact.